Why Scientists Are Revisiting a Polarizer

• by Rachana Pradhan

• February 10, 2026

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

• by Kathryn Wighton

• May 18, 2026

• 2 min

“Who’s on Backup?”—Exploring Internal Medicine Residency Backup Coverage Systems: Findings from a National Survey

• by Emily S. Wang, Joel C. Boggan, Emily Leasure, Daniel Kim, Lydia Redway, Erica N. Johnson, Patricia F. Kao, Steven J. Durning, Mark Rasnake

• May 18, 2026

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

• by Kathryn Wighton

• May 27, 2026

• 6 min